Welcome to visit us at SINOPEG's Booth #2351 at 2022 BIO International Convention, San Diego, CA, the USA from 13th to 16th June.
SINOPEG is a dynamic science company with professional R&D, Manufacturing and Sales capability. The company is mainly engaged in drug delivery system (DDS) and new medical materials business. Founded in 2011, SINOPEG has a high-level team with strong technical reserve to research, develop and produce high-quality polyethylene glycol, polyethylene glycol derivatives, block copolymers, anti-diabetic drug side chains, lipid excipients (ingredients for mRNA delivery system), ADC and ProTAC Linker, etc.
SINOPEG has a technical team led by overseas returned doctors and foreign experts, established good cooperation relations with well-known universities and research institutes in China, such as Xiamen University, Fudan University and the Institute of Chemistry of Chinese Academy of Sciences. The company has the first-class technology development strength, provides services including the reaction, purification, separation and end product analysis and others according to customer needs.
SINOPEG holds 24 IP, 19 pending IP, and 6 DMFs that meet FDA requirements. The company has ISO13485 certification. The laboratory and production workshop are designed and built in accordance with the cGMP standard of FDA. We follow the requirements of ICH-Q7A to organize production at scale, to provide high quality polyethylene glycol derivatives products and services to customers globally.
